Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLIPIZIDE vs GLOFITAMAB-GXBM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLIPIZIDE vs GLOFITAMAB-GXBM: Safety Overview

Metric GLIPIZIDE GLOFITAMAB-GXBM
Total FAERS Reports 4,099 498
Deaths Reported 552 175
Death Rate 13.5% 35.1%
Hospitalizations 1,030 113
Average Patient Age 63.4 yrs 60.0 yrs
% Female Patients 51.3% 36.2%
FDA Approval Date Apr 26, 1994 N/A
Manufacturer Bryant Ranch Prepack N/A
Route ORAL N/A
Marketing Status Discontinued Prescription